Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes-Reference-Cited by-同舟云学术

Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes

Published:2020-12 Issue: Volume:184 Page:104955
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Choi Seong Woo,Shin Jin Soo,Park Soon-Jung,Jung Eunhye,Park Yun-Gwi,Lee Jiho,Kim Sung Joon,Park Hun-Jun,Lee Jung-Hoon^ORCID,Park Sung-Min,Moon Sung-Hwan,Ban Kiwon^ORCID,Go Yun Young^ORCID

Funder

Ministry of Health and Welfare

Ministry of Trade, Industry & Energy

Korea Centers for Disease Control and Prevention

Ministry of Science and ICT

National Research Foundation of Korea

KRICT

City University of Hong Kong, Hong Kong SAR, China

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference40 articles.

1. Summary on Compassionate Use: Remdesivir Gilead;Agency,2020

2. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis;Aggarwal;Curr. Probl. Cardiol.,2020

3. Cardiovascular safety of potential drugs for the treatment of coronavirus disease 2019;Aggarwal;Am. J. Cardiol.,2020

4. Cardiovascular disease and COVID-19;Bansal;Diabetes Metabol. Syndr.,2020

5. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes;Bojkova;Cardiovasc. Res.,2020

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging biotechnologies for screening electromechanical signals of cardiomyocytes;Aggregate;2024-07

2. Remdesivir-Related Cardiac Adverse Effects in COVID-19 Patients: A Case-Control Study;Drug Research;2024-07

3. Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model;Cardiovascular Toxicology;2024-06-08

4. Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity;Molecular Pharmacology;2024-05-20

5. Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication;Viruses;2024-04-29